MP-20.23: Tolterodine extended release (TER) and/or Tamsulosin (TAM) in men with lower urinary tract symptoms (LUTS) including overactive bladder (OAB): effects of serum prostate-specific antigen (PSA) level
2007 ◽
Vol 10
(2)
◽
pp. 143-148
◽
2010 ◽
Vol 14
(2)
◽
pp. 100
◽
2004 ◽
Vol 93
(s1)
◽
pp. 21-26
◽
2009 ◽
Vol 42
(1)
◽
pp. 29-38
◽
2005 ◽
Vol 173
(6)
◽
pp. 2040-2043
◽